0 NASDAQ Companies - February 22, 2019Principia Biopharma Announces the Acceptance of Data from Phase 2 Pemphigus Vulgaris Trial as a Late-Breaking Presentation at 2019 American Academy of Dermatology MeetingRead More
0 NASDAQ Companies - February 22, 2019Fate Therapeutics to Present at the 8th Annual SVB Leerink Global Healthcare ConferenceRead More
0 NASDAQ Companies - February 22, 2019Great Elm Capital Corp. Announces Investment in Prestige Capital CorporationRead More
0 NASDAQ Companies - February 22, 2019Alder BioPharmaceuticals® Submits Biologics License Application to the U.S. Food and Drug Administration for EptinezumabRead More
0 NASDAQ Companies - February 22, 2019Krystal Biotech to Present at the 8th Annual SVB Leerink Global Healthcare ConferenceRead More
0 NASDAQ Companies - February 22, 2019Aptinyx to Present at 8th Annual SVB Leerink Global Healthcare ConferenceRead More
0 NASDAQ Companies - February 22, 2019Dermira Initiates Proof-of-Concept Study to Evaluate QBREXZA™ (glycopyrronium) Cloth in Patients with Primary Palmar HyperhidrosisRead More
0 NASDAQ Companies - February 22, 2019Calithera to Participate in the 8th Annual SVB Leerink Global Healthcare ConferenceRead More
0 NASDAQ Companies - February 22, 2019Obalon Announces Fourth Quarter and Full Year 2018 Financial ResultsRead More
0 NASDAQ Companies - February 22, 2019INAP to Release Fourth Quarter 2018 Financial Results on March 14, 2019Read More
